COMMODORE CAPITAL LP – Viridian Therapeutics, Inc. Transaction History
COMMODORE CAPITAL LP portfolio value:
$55.30M
portfolio value
COMMODORE CAPITAL LP quarter portfolio value change:
+77.27%
quarter
Viridian Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +64.55% | 1.05M shares | 36.34M | $20.51 | 2.69M |
| Q2 2022 | share | Increase | +72.24% | 687.27K shares | 1.36M | $11.57 | 1.63M |
| Q1 2022 | share | Increase | +12.23% | 103.65K shares | 831K | $18.49 | 951.33K |
| Q4 2021 | share | Increase | +26.96% | 180.00K shares | 5.77M | $20.3 | 847.68K |
| Q3 2021 | share | Increase | +258.18% | 481.26K shares | 7.57M | $16.45 | 667.67K |
| Q2 2021 | share | Increase | +0.34% | 624 shares | 305K | $18.29 | 186.40K |
| Q1 2021 | share | Increase | 0.00% | 185.78K shares | 3.10M | $16.71 | 185.78K |